IRIS - Res&Arch Institutional Research Information System - Research & Archive

EUSEBI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.446
EU - Europa 2.051
AS - Asia 452
SA - Sud America 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.959
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.446
IT - Italia 780
IE - Irlanda 552
HK - Hong Kong 210
UA - Ucraina 187
VN - Vietnam 121
FR - Francia 100
SE - Svezia 87
CN - Cina 81
RU - Federazione Russa 77
FI - Finlandia 66
DE - Germania 65
RO - Romania 39
GB - Regno Unito 32
TR - Turchia 21
CH - Svizzera 19
PL - Polonia 10
AT - Austria 9
BE - Belgio 9
GR - Grecia 6
UZ - Uzbekistan 6
NL - Olanda 5
SG - Singapore 5
JP - Giappone 4
IN - India 3
AR - Argentina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
EU - Europa 2
AU - Australia 1
BR - Brasile 1
MO - Macao, regione amministrativa speciale della Cina 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.959
Salva come PNG Salva come JPEG
Città #
Chandler 653
Dublin 552
San Mateo 258
Perugia 230
Hong Kong 208
Altamura 135
Wilmington 129
Dong Ket 121
Medford 113
Princeton 112
Lawrence 95
Jacksonville 91
Des Moines 79
Beijing 74
Andover 69
Ashburn 67
Ann Arbor 47
Rome 35
Bucharest 30
Milan 29
Los Angeles 23
Norwalk 23
Saint Petersburg 23
Salerno 21
Izmir 20
Falls Church 19
Redwood City 14
Helsinki 13
San Paolo di Civitate 13
Bologna 12
Dearborn 12
Houston 12
Boardman 11
Saint Louis 10
Brussels 9
Lausanne 9
Modena 9
Moscow 9
Seattle 9
Woodbridge 8
Fairfield 7
Laion 7
Catania 6
Chicago 6
Prato 6
Napoli 5
New York 5
Redmond 5
Tivoli 5
Amelia 4
Auburn Hills 4
Carlentini 4
Den Haag 4
Genova 4
Lucca 4
Trento 4
Turin 4
Verona 4
Cambridge 3
Cosenza 3
El Paso 3
Figline Valdarno 3
Florence 3
Frankfurt Am Main 3
Genoa 3
Mcallen 3
Mumbai 3
Naples 3
Parma 3
Saronno 3
Tappahannock 3
Timisoara 3
Abidjan 2
Agordo 2
Arlandastad 2
Bagnara Calabra 2
Burano 2
Cagliari 2
Castiglione Del Lago 2
Città Di Castello 2
Faenza 2
Federal 2
Fino Mornasco 2
Foligno 2
Gualtieri 2
Ladispoli 2
Latina 2
London 2
Mezzano 2
Montepulciano 2
Nagold 2
Padova 2
Pavia 2
Poggio a Caiano 2
Quartu Sant'elena 2
Radeberg 2
San Giovanni Lupatoto 2
Scottsdale 2
Seregno 2
Shanghai 2
Totale 3.592
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 337
CSF and blood biomarkers for Parkinson's disease 111
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 102
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 87
Multilevel Latent Class Models for evaluation of long term care facilities 76
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 74
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 73
Stima della non autosufficienza negli anziani in Umbria 69
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 68
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 63
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 62
Association between migraine and headache attributed to stroke: a case-control study. 61
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 61
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 61
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 61
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 60
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 59
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 59
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 59
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 58
Le condizioni di salute della popolazione anziana 57
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 57
Occipital arteriovenous malformations andmigraine. 56
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 56
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 55
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 55
A magnetization transfer study of mild and advanced Parkinson's disease. 54
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 53
Lysosomal enzyme activities in human brain 52
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 52
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 51
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 51
Underrecognition and undertreatment of dementia in Italian nursing homes. 51
Distorsione dell'immagine corporea nei DCA nei maschi 50
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 50
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 48
Dural arteriovenous fistulas and headache features: an observational study 48
Brain arteriovenous malformations and seizures: an Italian study. 47
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 47
Stima della non autosufficienza negli anziani in Umbria 46
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 46
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 46
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 45
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 45
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 44
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 44
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 44
Le condizioni di salute della popolazione anziana in Umbria 43
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 43
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 43
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 43
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 43
Latent variable modeling of disability in people aged 65 or more 43
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 43
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 42
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 42
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 42
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 42
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 42
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 41
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 41
Health technology disinvestment worldwide: Overview of programs and possible determinants 41
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 41
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 41
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 40
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 40
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 39
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 39
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 39
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 39
null 39
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 39
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 38
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 38
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 38
Multilevel Latent Class Models for evaluation of long term care facilities 37
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 37
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 37
Parkinson's and Lewy body dementia CSF biomarkers 37
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 36
Early management of patients with medication-overuse headache: results from a multicentre clinical study 36
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 36
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 36
Stima della non autosufficienza in Umbria. Anno 2007 e proiezioni al 2015 e 2020 35
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 35
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 34
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 34
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 34
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 34
Obsessive-compulsive disorder and migraine with medication-overuse headache. 33
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 31
Immunological profile of silent brain infarction and lacunar stroke. 31
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 31
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 31
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 31
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 31
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 30
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 30
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 29
Psychiatry in the emergency room: clinical experience in Perugia 28
Totale 4.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.618
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 24 4
2019/2020418 27 11 34 8 36 16 42 27 47 67 40 63
2020/2021715 11 29 17 53 256 18 36 43 66 17 31 138
2021/20221.066 10 189 10 26 39 15 17 279 42 74 197 168
2022/20232.015 123 393 27 174 132 246 6 94 716 5 59 40
2023/2024547 40 82 39 28 18 21 197 38 42 42 0 0
Totale 5.287